How Much Weight Will I Lose on 5mg of Mounjaro?

Last reviewed: July 12, 2026

Last updated: July 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide is a dual GLP-1 and GIP receptor agonist that signals your body to eat less and stabilize blood sugar. At 5mg—the starting dose—most people experience modest weight reduction in the first 4–8 weeks, but final results depend on your unique physiology, not just the number on the bottle.

What Does Clinical Research Show About 5mg Tirzepatide Weight Loss?

The SURMOUNT-1 clinical trial tracked tirzepatide doses ranging from 5mg to 15mg over 72 weeks. Participants on the 5mg dose alone lost approximately 8% of their starting body weight by week 72, though this reflects averages across a diverse population. When combined with lifestyle changes, some individuals achieved losses closer to 12–15%, while others saw more modest reductions of 3–5% at this entry dose.

Starting at 5mg is intentional: it allows your body to acclimate while minimizing nausea and gastrointestinal side effects. Many patients remain at this dose for 4–12 weeks before titrating upward. The initial phase establishes appetite control and metabolic shifts that create the foundation for progressive weight loss over time.

Individual Variation: Why Your Results May Differ From Average Data

Two people taking identical 5mg tirzepatide doses can experience vastly different outcomes because weight loss depends on genetics, starting body composition, age, activity level, and metabolic health. Your FTO gene variant (rs9939609), for example, influences how your body regulates fat storage and satiety signals—factors that directly impact how responsive you'll be to the medication at any dose.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Timeline and Dose Progression: What to Expect Beyond 5mg

Most patients begin tirzepatide at 5mg weekly and stay at this dose for 4 weeks to allow tolerance and assess initial weight loss. After that period, your healthcare provider typically increases to 7.5mg, then 10mg, and potentially to 15mg—each step spaced 4 weeks apart. Total weight loss accelerates as your dose increases, with the largest reductions often occurring between weeks 4–24.

The critical point: your dose may need to go up, but your price won't. PlexusDx charges a flat monthly rate at $289/mo month-to-month, or from $249/mo on the 6-month plan for compounded tirzepatide injection across all dose tiers, meaning progression to 7.5mg, 10mg, or 15mg carries no additional cost. This pricing model removes the financial barrier to optimal dosing.

How PlexusDx Personalizes Your Tirzepatide Journey

PlexusDx delivers compounded tirzepatide from licensed 503A pharmacies to all 50 states without requiring insurance or a membership fee. Your treatment plan is supervised by a physician who monitors your tolerability, appetite suppression, and weight loss at each dose level, adjusting progression based on your individual response rather than a one-size-fits-all schedule.

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will I lose 5 pounds per week on 5mg tirzepatide?

No. Typical weekly losses at the 5mg starting dose range from 0.5 to 2 pounds over the first 4–8 weeks. Dramatic weekly fluctuations are driven by water loss and temporary changes in appetite; sustainable fat loss becomes more apparent after 8–12 weeks as your metabolism stabilizes and dose increases.

What does clinical trial data actually say about tirzepatide weight loss?

SURMOUNT-1 showed participants on 5mg tirzepatide lost about 8% of body weight by 72 weeks. Higher doses (10mg, 15mg) produced 20–22% reductions over the same period. These are averages; individual outcomes depend on starting weight, genetics, adherence, and lifestyle factors.

How much does PlexusDx tirzepatide cost, and does the price change with my dose?

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) flat—and remains $289/mo whether you're at 5mg, 10mg, or 15mg. No per-dose fees, no hidden tiers. You pay one consistent price as your healthcare provider adjusts your dose for optimal results.

What are the side effects of 5mg tirzepatide, and how long do they last?

Common side effects at 5mg include mild nausea, constipation, and reduced appetite—typically mild at this low starting dose and often resolve within 1–2 weeks as your body adjusts. Severe or persistent side effects are uncommon at the 5mg dose; if they occur, your PlexusDx provider may recommend a slower titration or alternative medication.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

PlexusDx Precision Peptide Genetic Test doesn't predict an exact number, but it identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R—genes that influence appetite suppression, satiety, and metabolic efficiency. This insight helps your provider determine whether tirzepatide injection, oral tirzepatide, or a dual compound will work best for your physiology.

Related Reading

• Mounjaro For Losing Weight
• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.